All In Biotech

Drug Trial Radar · NCT04570423

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Patients With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

Last checked: Nov 20, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

May 20, 2021

Primary completion

Oct 2027

Study completion Oct 2027

Sponsor

Lead sponsor
Spectrum Pharmaceuticals, IncIndustry
Sponsor type
Industry
First posted
Sep 30, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 1 month, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and pharmacokinetics of eflapegrastim in pediatric participants with solid tumors or lymphoma and treated with myelosuppressive chemotherapy.

Conditions

  • Solid Tumors
  • Lymphoma

Interventions

  • EflapegrastimDrug

    Eflapegrastim supplied in prefilled, single-use syringes for SC injection.

  • ChemotherapyDrug

    Chemotherapy agents may include doxorubicin, ifosfamide, docetaxel, CHOP regimen, etoposide, cyclophosphamide and vincristine which will be administered as per standard of care per the Primary Care physician's treatment plan.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment Emergent Adverse Events (TEAEs)Time frame: From first dose of study drug to 35 days after the last dose of the study drug (Up to approximately 16 months)

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • New York Medical College

    Valhalla, New York · Terminated

  • Carolinas Medical Center/ Levine Children's Hospital

    Charlotte, North Carolina · Terminated

  • Levine Children's Health

    Charlotte, North Carolina · Terminated

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio · Recruiting

  • UT MD Anderson Cancer Center

    Houston, Texas · Terminated

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.